Skip to main content

Beneficial ownership — 13D / 13G

87,240 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
(s). of above person(s) (entities only) Rory O’Driscoll WKME WalkMe Ltd. Ordinary Shares 13G/A 10.41% 2y
THOMAS M SIEBEL AI C3.ai, Inc. 13G/A 22% 2y
William P. Foley, II DNB Dun & Bradstreet Holdings, Inc. 13G/A 3.4% 2y
Martin Hoffmann ONON On Holding AG 13G/A 17.4% 2y
BARROW HANLEY MEWHINNEY & STRAUSS LLC VRT Vertiv Holdings Co 13G 6% 2y
Institutional Venture Partners XIV, L.P. NRDS Nerdwallet, Inc. 13G/A 0% 2y
Vivo Opportunity Fund Holdings, L.P. RZLT Rezolute, Inc. 13G/A 8.2% 2y
Voss Capital, LP BXC BlueLinx Holdings Inc. 13G/A 7.4% 2y
Karpus Management, Inc. HSPOF Horizon Space Acquisition I Corp. 13G 6.97% 2y
MMCAP International Inc. SPC HLSQ Tessera Defense & Homeland Security Inc. 13G/A 3.22% 2y
GMT Capital Corp FFWM First Foundation Inc. 13G/A 0% 2y
Vulcan Value Partners, LLC SMRT SmartRent, Inc. 13G/A 4.83% 2y
Boston Partners AXTA Axalta Coating Systems Ltd. 13G/A 2.02% 2y
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC FFIV F5, Inc. 13G/A 8.41% 2y
Stonepine Capital Management, LLC ATYR aTYR PHARMA INC 13G/A 0.8% 2y
LucasZoom, LLC LZ Legalzoom.Com, Inc. 13G/A 0% 2y
Burgundy Asset Management Ltd. BRDG Bridge Investment Group Holdings Inc. 13G/A 0.07% 2y
Mizuho Financial Group, Inc. TWOA two 13G 7.01% 2y
Boston Partners EG Everest Group, Ltd. 13G/A 2.12% 2y
BOOTHBAY FUND MANAGEMENT, LLC BRLS Borealis Foods Inc. 13G/A 6.3% 2y
AMERICAN INTERNATIONAL GROUP, INC. CRBG Corebridge Financial, Inc. 13G/A 51.38% 2y
SUVRETTA CAPITAL MANAGEMENT, LLC SYRE Spyre Therapeutics, Inc. 13G/A 1% 2y
VR Advisory Services Ltd PANL Pangaea Logistics Solutions Ltd. 13G/A 0.4% 2y
Berkshire Partners Holdings LLC PTLO Portillo's Inc. 13G/A 30.6% 2y
Mizuho Financial Group, Inc. ARYD ARYA Sciences Acquisition Corp IV Class A Odinary Shares 13G 7.94% 2y
BB Biotech AG WVE Wave Life Sciences, Inc. 13G/A 3.7% 2y
Polar Asset Management Partners Inc. USAR USA Rare Earth, Inc. 13G 6% 2y
NORGES BANK ARE Alexandria Real Estate Equities, Inc. 13G/A 9.47% 2y
MACKENZIE FINANCIAL CORP STN Stantec Inc 13G/A 8.51% 2y
J. Alberto Arias LGO Largo Inc. 13G/A 43.86% 2y
JANUS HENDERSON GROUP PLC LRMR Larimar Therapeutics, Inc. 13G/A 6% 2y
BCPE Fund X Goose Holdings, L.P. GOOS Canada Goose Holdings Inc. 13G/A 25.1% 2y
SB INVESTMENT ADVISERS (UK) LTD GRAB Grab Holdings Ltd 13G/A 14.5% 2y
Mizuho Financial Group, Inc. GCTS GCT Semiconductor Holding, Inc. 13G 7.83% 2y
Thrivent Financial for Lutherans USLM United States Lime & Minerals Inc 13G/A 5.24% 2y
Dodge & Cox TIGO Millicom International Cellular SA 13G/A 5% 2y
Baiju Bhatt HOOD Robinhood Markets, Inc. 13G/A 9.3% 2y
Polar Asset Management Partners Inc. INTE Integral Acquisition Corporation 1 Class A Common Stock 13G/A 0% 2y
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC APAM Artisan Partners Asset Management Inc. 13G/A 9.57% 2y
Independent Franchise Partners LLP RBA Rb Global Inc. 13G 8.4% 2y
EJF Capital LP BYFC Broadway Financial Corp De 13G/A 0.9% 2y
Tikvah Management LLC GPGI GPGI, Inc. 13G/A 9.8% 2y
Hartree Partners, LP SGU Star Group, L.P. 13G/A 8.78% 2y
MVM Partners, LLC FNA Paragon 28, Inc. 13G/A 13.2% 2y
Michael P. Connors III Information Services Group Inc. 13G/A 9.7% 2y
JANUS HENDERSON GROUP PLC SRPT Sarepta Therapeutics, Inc. 13G/A 5.7% 2y
Amova Asset Management Americas, Inc. NXDR Nextdoor Holdings, Inc. 13G 5.29% 2y
GENERAL ATLANTIC, L.P. BLND Blend Labs, Inc. 13G/A 8% 2y
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC PRLD Prelude Therapeutics Inc 13G/A 0% 2y
Avidity Partners Management LP FUSN Fusion Pharmaceuticals Inc. Common Shares 13G/A 8.1% 2y